HPRA Drug Safety Newsletter Edition 89
Download:
hpra-drug-safety-newsletter-edition-89.pdf
219 KB
The latest edition of the HPRA Drug Safety Newsletter (DSN) includes important updates to support the safe and appropriate use of the following medicines:
Xofigo (radium-223 dichloride) - New restrictions for use
Varenicline (Champix) - Product Information Update - Reports of transient loss of consciousness
Oral Methotrexate - Updates to Product Information
Adverse Reactions Reporting - Update
« Back